![Report Asia-Pacific - Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses - Market Analysis, Forecast, Size, Trends and Insights for 499$](/landing/img/reports/asia-pacific-non-antibiotic-non-hormone-non-alkaloid-medicaments-for-therapeutic-or-prophylactic-uses-market-analysis-forecast-size-trends-and-insights.webp)
Asia-Pacific - Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses - Market Analysis, Forecast, Size, Trends and Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingAsia-Pacific: Market for Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments For Therapeutic Or Prophylactic Uses 2024
Market Size for Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments For Therapeutic Or Prophylactic Uses in Asia-Pacific
In 2023, the Asia-Pacific market for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses decreased by X% to $X for the first time since 2020, thus ending a two-year rising trend. Overall, consumption enjoyed a buoyant increase. Over the period under review, the market reached the maximum level at $X in 2022, and then reduced notably in the following year.
Production of Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments For Therapeutic Or Prophylactic Uses in Asia-Pacific
In value terms, production of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses fell dramatically to $X in 2023 estimated in export price. In general, production, however, saw a strong increase. The most prominent rate of growth was recorded in 2015 with an increase of X%. Over the period under review, production of attained the peak level at $X in 2022, and then shrank markedly in the following year.
Exports of Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments For Therapeutic Or Prophylactic Uses
Exports in Asia-Pacific
After three years of growth, overseas shipments of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses decreased by X% to X tons in 2023. Total exports indicated a mild expansion from 2012 to 2023: its volume increased at an average annual rate of X% over the last eleven years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. The most prominent rate of growth was recorded in 2021 when exports increased by X% against the previous year. Over the period under review, the exports of reached the maximum at X tons in 2022, and then contracted remarkably in the following year.
In value terms, exports of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses shrank slightly to $X in 2023. Total exports indicated a mild expansion from 2012 to 2023: its value increased at an average annual rate of X% over the last eleven years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. The growth pace was the most rapid in 2018 when exports increased by X% against the previous year. Over the period under review, the exports of reached the peak figure at $X in 2022, and then reduced slightly in the following year.
Exports by Country
China (X tons) and India (X tons) represented roughly X% of total exports in 2023. It was distantly followed by Singapore (X tons), generating a X% share of total exports. The following exporters - Australia (X tons), Nepal (X tons) and Taiwan (Chinese) (X tons) - together made up X% of total exports.
From 2012 to 2023, the biggest increases were recorded for Singapore (with a CAGR of X%), while shipments for the other leaders experienced more modest paces of growth.
In value terms, China ($X), Singapore ($X) and India ($X) appeared to be the countries with the highest levels of exports in 2023, together comprising X% of total exports.
In terms of the main exporting countries, Singapore, with a CAGR of X%, recorded the highest rates of growth with regard to the value of exports, over the period under review, while shipments for the other leaders experienced more modest paces of growth.
Export Prices by Country
In 2023, the export price in Asia-Pacific amounted to $X per ton, picking up by X% against the previous year. In general, the export price, however, saw a relatively flat trend pattern. The pace of growth was the most pronounced in 2018 an increase of X% against the previous year. The level of export peaked at $X per ton in 2012; however, from 2013 to 2023, the export prices failed to regain momentum.
There were significant differences in the average prices amongst the major exporting countries. In 2023, amid the top suppliers, the country with the highest price was Australia ($X per ton), while Nepal ($X per ton) was amongst the lowest.
From 2012 to 2023, the most notable rate of growth in terms of prices was attained by China (X%), while the other leaders experienced mixed trends in the export price figures.
Imports of Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments For Therapeutic Or Prophylactic Uses
Imports in Asia-Pacific
In 2023, overseas purchases of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses increased by X% to X tons, rising for the third consecutive year after three years of decline. Over the period under review, imports showed moderate growth. The pace of growth appeared the most rapid in 2022 when imports increased by X% against the previous year. Over the period under review, imports of attained the maximum in 2023 and are likely to see steady growth in the immediate term.
In value terms, imports of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses shrank to $X in 2023. The total import value increased at an average annual rate of X% from 2012 to 2023; however, the trend pattern indicated some noticeable fluctuations being recorded throughout the analyzed period. The most prominent rate of growth was recorded in 2021 with an increase of X% against the previous year. The level of import peaked at $X in 2022, and then contracted in the following year.
Imports by Country
In 2023, Australia (X tons) represented the major importer of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses, committing X% of total imports. It was distantly followed by India (X tons), China (X tons), South Korea (X tons) and Thailand (X tons), together generating a X% share of total imports. Japan (X tons), Nepal (X tons), Malaysia (X tons), Bangladesh (X tons), Vietnam (X tons), Afghanistan (X tons) and Sri Lanka (X tons) held a relatively small share of total imports.
Imports into Australia increased at an average annual rate of X% from 2012 to 2023. At the same time, China (X%), India (X%), Afghanistan (X%), Sri Lanka (X%), Bangladesh (X%), Nepal (X%), Japan (X%), Thailand (X%) and Malaysia (X%) displayed positive paces of growth. Moreover, China emerged as the fastest-growing importer imported in Asia-Pacific, with a CAGR of X% from 2012-2023. By contrast, South Korea (X%) and Vietnam (X%) illustrated a downward trend over the same period. From 2012 to 2023, the share of Australia, China and India increased by X, X and X percentage points, respectively. The shares of the other countries remained relatively stable throughout the analyzed period.
In value terms, China ($X), Japan ($X) and South Korea ($X) constituted the countries with the highest levels of imports in 2023, with a combined X% share of total imports. India, Thailand, Australia, Nepal, Bangladesh, Vietnam, Afghanistan, Malaysia and Sri Lanka lagged somewhat behind, together accounting for a further X%.
Among the main importing countries, Nepal, with a CAGR of X%, recorded the highest growth rate of the value of imports, over the period under review, while purchases for the other leaders experienced more modest paces of growth.
Import Prices by Country
In 2023, the import price in Asia-Pacific amounted to $X per ton, falling by X% against the previous year. Over the period under review, the import price showed a pronounced setback. The most prominent rate of growth was recorded in 2013 when the import price increased by X%. The level of import peaked at $X per ton in 2020; however, from 2021 to 2023, import prices failed to regain momentum.
There were significant differences in the average prices amongst the major importing countries. In 2023, amid the top importers, the country with the highest price was Japan ($X per ton), while Australia ($X per ton) was amongst the lowest.
From 2012 to 2023, the most notable rate of growth in terms of prices was attained by Nepal (X%), while the other leaders experienced more modest paces of growth.
Source: IndexBox Platform
This report provides an in-depth analysis of the market for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses in Asia-Pacific. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21201320 - Other medicaments for therapeutic or prophylactic uses, of HS
Country coverage:
- Afghanistan
- American Samoa
- Australia
- Bangladesh
- Bhutan
- Brunei Darussalam
- Cambodia
- China
- Cook Islands
- Democratic People's Republic of Korea
- Fiji
- French Polynesia
- Guam
- Hong Kong SAR
- India
- Indonesia
- Japan
- Kiribati
- Lao People's Democratic Republic
- Macao SAR
- Malaysia
- Maldives
- Marshall Islands
- Micronesia
- Myanmar
- Nauru
- Nepal
- New Caledonia
- New Zealand
- Niue
- Northern Mariana Islands
- Pakistan
- Palau
- Papua New Guinea
- Philippines
- Samoa
- Singapore
- Solomon Islands
- South Korea
- Sri Lanka
- Taiwan (Chinese)
- Thailand
- Timor-Leste
- Tokelau
- Tonga
- Tuvalu
- Vanuatu
- Vietnam
- Wallis and Futuna Islands
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Production in Asia-Pacific, split by region and country
- Trade (exports and imports) in Asia-Pacific
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- CONSUMPTION BY COUNTRY
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
- PRODUCTION BY COUNTRY
8. IMPORTS
The Largest Importers on The Market and How They Succeed
- IMPORTS FROM 2012–2023
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Exporters on The Market and How They Succeed
- EXPORTS FROM 2012–2023
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO -
11. COUNTRY PROFILES
The Largest Markets And Their Profiles
This Chapter is Available Only for the Professional Edition PRO- Afghanistan
- Australia
- Bangladesh
- Bhutan
- Brunei Darussalam
- Cambodia
- China
- Hong Kong SAR
- Macao SAR
- Cook Islands
- Fiji
- French Polynesia
- India
- Indonesia
- Japan
- Kiribati
- Malaysia
- Maldives
- Marshall Islands
- Micronesia
- Myanmar
- Nepal
- New Caledonia
- New Zealand
- Northern Mariana Islands
- Pakistan
- Palau
- Papua New Guinea
- Philippines
- Samoa
- Singapore
- Solomon Islands
- South Korea
- Sri Lanka
- Taiwan (Chinese)
- Thailand
- Timor-Leste
- Tokelau
- Tonga
- Tuvalu
- Vanuatu
- Vietnam
- Wallis and Futuna Islands
- Lao People's Democratic Republic
- American Samoa
- Democratic People's Republic of Korea
- Nauru
- Niue
- Guam
-
LIST OF TABLES
- Key Findings In 2023
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Per Capita Consumption, By Country, 2018–2023
- Production, In Physical Terms, By Country, 2012–2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Destination, 2012–2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Origin, 2012–2023
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Consumption, By Country, 2023
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2023
- Production, In Value Terms, 2012–2023
- Production, By Country, 2023
- Production, In Physical Terms, By Country, 2012–2023
- Imports, In Physical Terms, 2012–2023
- Imports, In Value Terms, 2012–2023
- Imports, In Physical Terms, By Country, 2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country, 2012–2023
- Exports, In Physical Terms, 2012–2023
- Exports, In Value Terms, 2012–2023
- Exports, In Physical Terms, By Country, 2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, 2012–2023
Recommended reports
This report provides an in-depth analysis of the market for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses in Asia.
This report provides an in-depth analysis of the market for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses in the U.S..
This report provides an in-depth analysis of the market for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses in China.
This report provides an in-depth analysis of the market for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses in the EU.
This report provides an in-depth analysis of the global market for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses.
- Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses Market
- Frozen and Fresh or Chilled Skipjack Tuna Market
- Frozen Market
- Frozen Scallops Market
- Jellyfish Market
- Non-Citrus Fruits not Elsewhere Classified Market
- Battered Fish Fillet Market
- Molasse Market
- Crispbread Market
- Gingerbread Market